OCULAR THERAPEUTIX, INC
Profile
Company Names
OCULAR THERAPEUTIX, INC
I-THERAPEUTIX INC
Addresses
15 CROSBY DRIVE, BEDFORD, MA 01730
36 CROSBY DRIVE, SUITE 101, BEDFORD, MA 01730
235 BEAR HILL RD SUITE 301, WALTHAM, MA 02451
Phone Numbers
781-357-4000
781-895-3235
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2006
State Incorporated:
DELAWARE
Total Amount Raised:
$88,145,839.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2019-03-01
$37,500,000.00
$37,500,000.00
$0.00
Debt
5
2013-05-31
$8,500,002.00
$8,500,002.00
$0.00
Equity
4
2011-02-01
$14,000,001.00
$14,000,001.00
$0.00
Equity
3
2009-06-19
$21,000,000.00
$21,000,000.00
$0.00
Equity
2
2008-01-25
$6,000,000.00
$6,000,000.00
$0.00
1
2006-10-30
$1,145,836.00
$1,145,836.00
$0.00
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN
CAGNETTA
EXECUTIVE OFFICER
ALAN
CRAIN
EXECUTIVE OFFICER, DIRECTOR
ALAN
CRANE
EXECUTIVE OFFICER, DIRECTOR
CERULEAN PHARMA INC.
| PARASOL THERAPEUTICS INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| VISTERRA, INC.
| EXPERIMENT FUND, LLC
| OCULAR THERAPEUTIX, INC
| CALORICS, INC.
| XTUIT PHARMACEUTICALS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| PANDION THERAPEUTICS, INC.
| SEISMIC THERAPEUTIC, INC.
JAMES
GARVEY
EXECUTIVE OFFICER, DIRECTOR
CARDIOFOCUS, INC.
| CELLUTIONS INC
| CHF SOLUTIONS INC
| SV LIFE SCIENCES FUND V LP
| SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.
| OCULAR THERAPEUTIX, INC
| HALSCION INC
| LASALLE PROPERTY FUND, L.P.
| ACUFOCUS, INC.
| SELF LENDER, INC.
| SV LIFE SCIENCES FUND VI, L.P.
| SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.
| LPF MEMORIAL HERMANN REIT TRUST
| SELF FINANCIAL, INC.
| FRONTLINE EMEA EXPANSION FUND LP
| LPF 1 TECHNOLOGY DRIVE REIT, LLC
| ESS-LPF STORAGE REIT LLC
MICHAEL
GOLDSTEIN
EXECUTIVE OFFICER
FARHAD
KHOSRAVI
DIRECTOR, EXECUTIVE OFFICER
ACCESS CLOSURE, INC.
| SADRA MEDICAL, INC.
| SQUAREONE INC
| SQUAREONE, INC.
| HOTSPUR TECHNOLOGIES INC
| I-THERAPEUTIX INC
| AUGMENIX INC
| APAMA MEDICAL, INC.
| MAYA MEDICAL, INC.
| OCULAR THERAPEUTIX, INC
| CLARET MEDICAL, INC.
| STROKE PROJECT, INC.
| INSTYLLA, INC.
| TULAVI THERAPEUTICS, INC.
| OSTIAL CORP
| IMPERATIVE CARE, INC.
| TRUVIC MEDICAL, INC.
| REJONI, INC.
BRIAN
LEVY
DIRECTOR
RICHARD
LINDSTROM
DIRECTOR
VERTICAL HEALTH SOLUTIONS INC
| OCULAR THERAPEUTIX, INC
| FORSIGHT VISION6, INC.
| ENCORE VISION, INC.
| ALPHAEON CORP
| TEARLAB CORP
| POGOTEC, INC.
| IMPRIMIS PHARMACEUTICALS, INC.
| SIGHTLIFE SURGICAL, INC.
| UNITED VISION PARTNERS HOLDINGS, LLC
| EQUINOX, INC.
| IANTECH, INC.
| CORNEAGEN INC.
| EQUINOX OPHTHALMIC, INC.
| THEROPTIX, INC.
| LENTECHS LLC
| SURFACE OPHTHALMICS, INC.
| SYDNEXIS, INC.
| CG HOLDING CO.
| IOR HOLDINGS, INC.
| VINCI PHARMACEUTICALS, INC.
RICHARD
L.
LINDSTROM
DIRECTOR
DANIEL
MYERS
EXECUTIVE OFFICER, DIRECTOR
BRUCE
A.
PEACOCK
DIRECTOR
AMARPREET
SAWHNEY
EXECUTIVE OFFICER, DIRECTOR
CHARLES
WARDEN
DIRECTOR, EXECUTIVE OFFICER
SAMUEL
WU
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2019-03-01

